|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Consolidated Entity excluding Consolidated Investment Products | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Consolidated Entity excluding Consolidated Investment Products | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Cash pledged or on deposit of CIP | ||||||||||||||||||||
| Furniture, equipment and leasehold improvements, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred taxes, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Consolidated Entity excluding Consolidated Investment Products | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Investment manager noncontrolling interests liability | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Notes payable of CIP | ||||||||||||||||||||
| Securities purchased payable and other liabilities of CIP | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Equity attributable to Virtus Investment Partners, Inc.: | ||||||||||||||||||||
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 12,390,279 shares issued and 6,622,622 shares outstanding at June 30, 2026; and 12,319,278 shares issued and 6,695,181 shares outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost, 5,767,657 and 5,624,097 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total equity attributable to Virtus Investment Partners, Inc. | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Consolidated Investment Products | ||||||||||||||||||||
| Total noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
